This work was supported in part by the grants from the National Natural Science Foundation of China(Nos.82160175 and 81460173);the Science and Technology Department of Yunnan Province(Nos.2017FF117(-062)and 2019FE001(-023)).
Resveratrol (RSV) could promote osteogenic activity, but its clinical application has been hampered in view of its poor bioavailability. Therefore, it is desirable to identify with certainty the molecular target of it...